QNCX Earnings

Quarterly EPS
$-26.00
Q3 2024
$-56.91
Q4 2024
$-68.40
Q1 2025
$-68.75
Q2 2025
$-50.00
Q3 2025
$-55.65
Q4 2025
$72.00
Q1 2026
$-12.31
Q2 2026
Latest RevenueN/A
Latest Net Income-75488000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$12.310-75488000+82.1%
Q1 2026$72.00035.9M+205.3%
Q4 2025-$55.650-39458000+2.2%
Q3 2025-$50.000-13442000-92.3%
Q2 2025-$68.750-16049000+46.3%
Q1 2025-$68.400-15030000-31.5%
Q4 2024-$56.910-12458000-31.5%
Q3 2024-$26.000-5492000+13.3%
Q2 2024-$128.000-27729000
Q1 2024-$52.000-11149000
Q4 2023-$43.280-8894000
Q3 2023-$30.000-5351000
Quince Therapeutics (QNCX) — Earnings